JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Home・Elenco Azioni・Boston Scientific Corp.

Boston Scientific Corp.

Chiusa

SettoreSettore sanitario

55.97 -1.62

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

55.87

Massimo

56.99

Metriche Chiave
By Trading Economics
Entrata	-83M 672M
Vendite	-83M 5.2B
P/E Media del settore	25.084 67.147
EPS	0.8
Margine di Profitto	12.713
Dipendenti	59,000
EBITDA	116M 1.1B

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+56.76% upside

Dividendi
By Dow Jones
Utili prossimi	29 lug 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-1.5B 89B
Apertura precedente	57.59
Chiusura precedente	55.97

Notizie sul Sentiment di mercato

By Acuity

51%

49%

281 / 347 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

102.95 / 104.93 Supporto e resistenza

Boston Scientific Corp. Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 apr 2026, 11:22 UTC

Utili

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View

4 feb 2026, 16:14 UTC

Utili

I principali Market Mover

Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat

4 feb 2026, 12:13 UTC

Utili

Boston Scientific Sees More Growth after Earnings, Sales Rise

22 apr 2026, 11:07 UTC

Utili

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adj EPS View

22 apr 2026, 10:32 UTC

Utili

Boston Scientific Now Sees 2026 Reported Sales Up 7%-8.5%, Organic Sales Up 6.5%-8% >BSX

22 apr 2026, 10:31 UTC

Utili

Boston Scientific Sees 2Q Reported Sales Up 5.5%-7.5%, Organic Sales Up 5%-7% >BSX

22 apr 2026, 10:30 UTC

Utili

Boston Scientific 1Q Organic Sales Up 9.4% >BSX

22 apr 2026, 10:30 UTC

Utili

Boston Scientific 1Q Adj EPS 80c >BSX

22 apr 2026, 10:30 UTC

Utili

Boston Scientific 1Q EPS 90c >BSX

22 apr 2026, 10:30 UTC

Utili

Boston Scientific 1Q Sales $5.2B >BSX

22 apr 2026, 10:30 UTC

Utili

Boston Scientific Sees 2Q Adj EPS 82c-Adj EPS 84c >BSX

22 apr 2026, 10:30 UTC

Utili

Boston Scientific Sees FY Adj EPS $3.34-Adj EPS $3.41 >BSX

30 mar 2026, 15:34 UTC

Discorsi di Mercato

Boston Scientific Faces Some Slowing Growth Trends -- Market Talk

4 feb 2026, 21:41 UTC

Utili

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 feb 2026, 19:38 UTC

Utili

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 feb 2026, 17:32 UTC

Utili

These Stocks Are Today's Movers: AMD, AbbVie, Eli Lilly, Boston Scientific, MP Materials, Super Micro, Silicon Labs, Uber, and More -- Barrons.com

4 feb 2026, 15:30 UTC

Utili

Boston Scientific Earnings Beat Estimates. It's the Worst Stock in the S&P 500 Today. -- Barrons.com

4 feb 2026, 15:29 UTC

Utili

These Stocks Are Today's Movers: AMD, Eli Lilly, AbbVie, Uber, Super Micro, Enphase, Boston Scientific, and More -- Barrons.com

4 feb 2026, 14:06 UTC

Utili

Boston Scientific Profit, Sales Rise but Issues Soft Guidance -- Update

4 feb 2026, 13:58 UTC

Utili

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4 feb 2026, 13:12 UTC

Utili

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4 feb 2026, 11:32 UTC

Utili

Boston Scientific Sees 2026 Sales Up 10.5%-11.5%, Organic Sales Up 10%-11% >BSX

4 feb 2026, 11:31 UTC

Utili

Boston Scientific Sees 1Q Sales Up 10.5%-12%, Organic Sales Up 8.5%-10% >BSX

4 feb 2026, 11:30 UTC

Utili

Boston Scientific 4Q Organic Sales Up 12.7% >BSX

4 feb 2026, 11:30 UTC

Utili

Boston Scientific Sees 2026 Adj EPS $3.43-Adj EPS $3.49 >BSX

4 feb 2026, 11:30 UTC

Utili

Boston Scientific Sees 1Q Adj EPS 78c-Adj EPS 80c >BSX

4 feb 2026, 11:30 UTC

Utili

Boston Scientific 4Q Adj EPS 80c >BSX

4 feb 2026, 11:30 UTC

Utili

Boston Scientific 4Q Sales $5.29B >BSX

4 feb 2026, 11:30 UTC

Utili

Boston Scientific 4Q EPS 45c >BSX

24 gen 2026, 06:18 UTC

Acquisizioni, Fusioni, Takeovers

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Boston Scientific Corp. Previsione

Obiettivo di Prezzo

By TipRanks

56.76% in crescita

Previsioni per 12 mesi

Media 89.12 USD 56.76%

Alto 118 USD

Basso 71 USD

Basato su 27 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Boston Scientific Corp. - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

27 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 27 che hanno fornito valutazioni azionarie a Boston Scientific Corp. - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

102.95 / 104.93Supporto e resistenza

All events are bullish.

Recent bearish events outweigh bullish events.

There are no events.

Sentiment

By Acuity

281 / 347 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.